Pricing Log in Create free account
Friday 6 November 2026 Export LIVN’s income statement to Excel — free account

LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024.

Revenue
+9.88%
EPS
+27.4%
Free cash flow
−31.0%
Total debt
−31.2%

Quarter to September 2026, against a year earlier

90.77 0.37 −0.41%
Market cap
$5.0B
P/E
25.6×
Fwd P/E
19.8×
Dividend yield
—
F-score
4/9
Altman Z
1.74
Beneish M
−3.30
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

LivaNova PLC (LIVN) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, LivaNova PLC (LIVN) trades at a EV/Sales of 3.2×. Over the past ten years it has ranged from 1.4× (April 2025) to 6.1× (September 2018); the current reading is higher than 51% of that period. That is above the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.2× 15.78%
FY2024 1.9× (18.70%)
FY2023 2.4× (18.63%)
FY2022 2.9× (32.34%)
FY2021 4.3× 11.13%
FY2020 3.9× 7.07%
FY2019 3.6× (12.09%)
FY2018 4.1× 6.79%
FY2017 3.9× 61.91%
FY2016 2.4× (56.43%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 2.6× (10.22%)
Jun 2026 2.9× 29.84%
Mar 2026 2.2× 0.79%
Dec 2025 2.2× 13.60%
45 more quarters

Against its own ten years

Low 1.4× High 6.1×
Ten-year median 3.1×
Current reading's percentile 52

EV/Sales against peers

Company EV/Sales
BRKR Bruker Corporation compare 3.0×
ITGR Integer Holdings Corporation compare 3.0×
LIVN LivaNova PLC 3.2×
NEOG Neogen Corporation compare 3.6×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
HAE Haemonetics Corporation compare 4.7×
IRTC iRhythm Holdings, Inc. compare 5.2×
AXGN AxoGen, Inc. compare 8.8×
TXG 10x Genomics compare 11.5×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on LIVN